Restoration of plasticity after pediatric traumatic brain injury

小儿脑外伤后可塑性的恢复

基本信息

项目摘要

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is the single most important cause of death and disability in children and adolescents, yet relatively little is known about the underlying mechanisms that distinguish pediatric brain injury from that in adults. It is understood the traumatic biomechanical injury to the immature brain can manifest as chronic cognitive and behavioral problems with a loss of developmental potential. Plasticity is defined as a mechanism by which the brain modifies cellular and network structure and function to respond to changes in the environment. There is increasing evidence that pediatric TBI can result in impaired plasticity and alterations in neurotransmission. Glutamate represents the major excitatory neurotransmitter in the central nervous system and is intimately involved in the acute pathophysiology of TBI, but also is critical for normal development and for neural plasticity. This application proposes to investigate the glutamatergic response to TBI in the immature brain, in particular, that which involves the N-methyl-D-aspartate (NMDA) receptor. The central hypothesis of this proposal is that dysfunction at the NMDA receptor underlies the loss of plasticity seen following developmental TBI, and that this perturbation can be measured molecularly (Specific Aims 1 and 2), electrophysiologically (Specific Aim 3) and cognitively (Specific Aim 4), using a well-characterized experimental model of pediatric TBI. By determining the post-injury time course of changes in this important neurotransmitter system, it will be possible to identify the window of impaired neural responsiveness at the NMDA receptor. Proper identification of this time period will then direct the final aim (Specific Aim 5) of this application, which is to utilize pharmacological agents that augment NMDA receptor neurotransmission to normalize the molecular profile of the developing brain and to alleviate behavioral and cognitive deficits. This proposal provides a unique opportunity to rigorously test an age-specific therapeutic strategy that is designed to be beneficial for the patient population most vulnerable to TBI, children.
描述(由申请人提供):创伤性脑损伤(TBI)是儿童和青少年最重要的死亡和残疾原因,但对于将小儿脑损伤与成人区分开的基本机制相对较少。人们理解了对未成熟大脑的创伤性生物力学损伤可以表现为慢性认知和行为问题,而发育潜力的丧失。可塑性被定义为一种机制,大脑通过该机制修饰细胞结构和功能以应对环境变化。越来越多的证据表明,小儿TBI会导致可塑性受损和神经传递的改变。谷氨酸代表了中枢神经系统中主要的兴奋性神经递质,并且与TBI的急性病理生理学密切相关,但对于正常发育和神经可塑性至关重要。该应用建议研究未成熟大脑中对TBI的谷氨酸能反应,尤其是涉及N-甲基-D-天冬氨酸(NMDA)受体的谷氨酸能反应。该提议的核心假设是,NMDA受体的功能障碍是发育性TBI后看到的可塑性丧失的基础,并且可以使用良好的经验实验模型TBI的模型TB,可以用电生理学(特定的目标3)和认知(特定的目标4)来测量这种扰动(特定目的1和2),特定的目标4)和使用良好的实验模型。通过确定这种重要的神经递质系统变化的伤害后时间过程,可以识别NMDA受体处于神经反应受损的窗口。然后,正确识别此时期将指导该应用的最终目标(特定目的5),即利用增加NMDA受体神经传递的药理剂,以使发育中大脑的分子特征正常化并减轻行为和认知缺陷。该提案为严格测试特定年龄的治疗策略提供了一个独特的机会,该策略旨在对最容易受到TBI(TBI,儿童)的患者群体有益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER C GIZA其他文献

CHRISTOPHER C GIZA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER C GIZA', 18)}}的其他基金

Western Neurotrauma Symposium
西方神经创伤研讨会
  • 批准号:
    10754153
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
Western Neurotrauma Symposium
西方神经创伤研讨会
  • 批准号:
    10540633
  • 财政年份:
    2022
  • 资助金额:
    $ 17.81万
  • 项目类别:
CARE4Kids: Administrative Core
CARE4Kids:行政核心
  • 批准号:
    10203598
  • 财政年份:
    2021
  • 资助金额:
    $ 17.81万
  • 项目类别:
Endophenotypes of Persistent Post-Concussive Symptoms in Adolescents: CARE4Kids
青少年持续性脑震荡后症状的内表型:CARE4Kids
  • 批准号:
    10203603
  • 财政年份:
    2021
  • 资助金额:
    $ 17.81万
  • 项目类别:
RESTORATION OF PLASTICITY AFTER PEDIATRIC TRAUMATIC BRAIN INJURY
小儿脑外伤后可塑性的恢复
  • 批准号:
    8363462
  • 财政年份:
    2011
  • 资助金额:
    $ 17.81万
  • 项目类别:
RESTORATION OF PLASTICITY AFTER PEDIATRIC TRAUMATIC BRAIN INJURY
小儿脑外伤后可塑性的恢复
  • 批准号:
    8171118
  • 财政年份:
    2010
  • 资助金额:
    $ 17.81万
  • 项目类别:
RESTORATION OF PLASTICITY AFTER PEDIATRIC TRAUMATIC BRAIN INJURY
小儿脑外伤后可塑性的恢复
  • 批准号:
    7955733
  • 财政年份:
    2009
  • 资助金额:
    $ 17.81万
  • 项目类别:
RECOVERY FROM TRAUMATIC BRAIN INJURY IN ADOLESCENTS
青少年脑外伤的康复
  • 批准号:
    7724463
  • 财政年份:
    2008
  • 资助金额:
    $ 17.81万
  • 项目类别:
Restoration of plasticity after pediatric traumatic brain injury
小儿脑外伤后可塑性的恢复
  • 批准号:
    7187260
  • 财政年份:
    2007
  • 资助金额:
    $ 17.81万
  • 项目类别:
Restoration of plasticity after pediatric traumatic brain injury
小儿脑外伤后可塑性的恢复
  • 批准号:
    7386690
  • 财政年份:
    2007
  • 资助金额:
    $ 17.81万
  • 项目类别:

相似国自然基金

自然接触对青少年网络问题行为的作用机制及其干预
  • 批准号:
    72374025
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
大气污染物对青少年心理健康的影响机制研究
  • 批准号:
    42377437
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
  • 批准号:
    82373595
  • 批准年份:
    2023
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目
中国父母情绪教养行为对青少年非自杀性自伤的影响及其机制
  • 批准号:
    32300894
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
执行技能训练联合动机行为治疗对注意缺陷多动障碍青少年疗效及脑机制
  • 批准号:
    82371557
  • 批准年份:
    2023
  • 资助金额:
    65 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions
青少年神经发生和中风后恢复的机制:确定与年龄相关的神经免疫相互作用的作用
  • 批准号:
    10637874
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
感染和未感染艾滋病毒的幼儿结核感染的进展:PROTECT 研究
  • 批准号:
    10641389
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
  • 批准号:
    10651082
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
用于儿科 AML 可测量残留疾病监测的个性化分子检测的临床前验证
  • 批准号:
    10643568
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
Development of practical screening tools to support targeted prevention of early, high-risk drinking substance use
开发实用的筛查工具,以支持有针对性地预防早期高风险饮酒物质的使用
  • 批准号:
    10802793
  • 财政年份:
    2023
  • 资助金额:
    $ 17.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了